Trial Profile
Study of Electrophysiological Effects of NACOS and AVK on the Pulmonary Veins and the Left Atrium of Patients Referred for Paroxysmal AF Catheter Ablation
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Jun 2018
Price :
$35
*
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Fluindione (Primary) ; Rivaroxaban (Primary) ; Warfarin (Primary)
- Indications Stroke; Thromboembolism
- Focus Therapeutic Use
- Acronyms NACO-VP
- 08 Jul 2016 New trial record